Not logged in Share Save
Share Save
Share Save
Circulating Tumor Cells: Origin, Role, Current Applications, and Future Perspectives for Personalized Medicine Rapanotti, Maria Cristina; Cenci, Tonia; Scioli, Maria Giovanna; Cugini, Elisa; Anzillotti, Silvia; Savino, Luca; Coletta, Deborah; Di Raimondo, Cosimo; Campione, Elena; Roselli, Mario; Bernardini, Sergio; Bianchi, Luca; De Luca, Anastasia; Ferlosio, Amedeo; Orlandi, Augusto Share Save
Importance of prompt medical oncologist (MO) consultation at the Emergency Department (ED): A prospective study in a tertiary hospital on 10,896 admissions in the first quarter of 2024 Morelli, C.; Mea, M.; Bonomo, M. V.; Meacci, A.; Naccarelli, T.; Rofei, M.; Parisi, G.; Flaminio, V.; Riondino, S.; Di Lecce, V. N.; Paganelli, C.; Legramante, J. M.; Roselli, M.; Formica, V. Share Save
Implementing fencing as adapted physical activity in non-metastatic breast cancer patients: design and early rehabilitation strategy of the FENICE study protocol Berretta, Massimiliano; Garozzo, Daniele; Foti, Calogero; Roselli, Mario; Materazzo, Marco; Vita, Giulia; Iellamo, Ferdinando; Scordari, Marco; Di Mauro, Giordana; Spatari, Giovanna; Ottaiano, Alessandro; Noce, Annalisa; Pelicciaro, Marco; Bignucolo, Alessia; Vanni, Gianluca; Buonomo, Oreste Claudio Share Save
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: A retrospective study Rosenfeld, R.; Riondino, S.; Cerocchi, M.; Luciano, A.; Idone, G.; Lecis, D.; Illuminato, F.; Tolomei, A.; Torino, F.; Chiocchi, M.; Roselli, M. Share Save
Share Save
Share Save
Share Save
Efficacy study of osimertinib in treatment-naive patients with EGFR mutant non-small cell lung cancer (NSCLC) according to TP53 mutational status (TEMPLE-2/ NCT05785208) Vitale, A.; Pilotto, S.; Monaca, F.; Belluomini, L.; Valente, G.; Giannone, L.; Berardi, R.; Bironzo, P.; Ceribelli, A.; Galetta, D.; Gelibter, A. J.; Lugini, A.; Roselli, M.; Tiseo, M.; Scotti, V.; Giannarelli, D.; Scarpa, A.; Milella, M.; Tortora, G.; Bria, E. Share Save
Share Save
Share Save
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling Formica, Vincenzo; Riondino, Silvia; Morelli, Cristina; Guerriero, Simona; D'Amore, Federica; Di Grazia, Antonio; Blanco, Giovanna Del Vecchio; Sica, Giuseppe; Arkenau, Hendrik-Tobias; Monteleone, Giovanni; Roselli, Mario Share Save
Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and Trastuzumab Chiocchi, Marcello; Cerocchi, Martina; Di Tosto, Federica; Rosenfeld, Roberto; Pasqualetto, Monia; Vanni, Gianluca; De Stasio, Vincenzo; Pugliese, Luca; Di Donna, Carlo; Idone, Gaetano; Muscoli, Saverio; Portarena, Ilaria; Roselli, Mario; Garaci, Francesco; Floris, Roberto Share Save
Share Save
Irinotecan is superior to oxaliplatin in KRAS-G12C-mutated (K-G12C-m) colorectal cancer (CRC) and should be preferred in combination strategies with K-G12C inhibitors. A multicenter propensity score-matched (PSM) retrospective analysis Morelli, C.; Lucchetti, J.; Calegari, M. A.; Rofei, M.; Guerriero, S.; Riondino, S.; Flaminio, V.; Parisi, G.; Lo Prinzi, F.; Trovato, G.; Vincenzi, B.; Salvatore, L.; Roselli, M.; Formica, V. Share Save
Phase III study with FOLFIRI/cetuximab versus FOLFIRI/cetuximab followed by cetuximab (Cet) alone in first-line therapy of RAS and BRAF wild-type (wt) metastatic colorectal cancer (mCRC) patients: The ERMES study Pinto, C.; Orlandi, A.; Normanno, N.; Maiello, E.; Calegari, M. A.; Antonuzzo, L.; Bordonaro, R.; Zampino, M. G.; Pini, S.; Bergamo, F.; Tonini, G.; Avallone, A.; Latiano, T. P.; Rosati, G.; Pazzola, A.; Ballestrero, A.; Zaniboni, A.; Roselli, M.; Tamberi, S.; Barone, C. A. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Not logged in.png){kind=icon}